Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.5 GBX | 0.00% |
|
+7.69% | +12.90% |
06-14 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
06-14 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.90% | 34.28M | |
-26.92% | 16.07B | |
-50.73% | 2.43B | |
+27.80% | 2.02B | |
-7.88% | 1.53B | |
+25.65% | 1.29B | |
-19.07% | 931M | |
-32.38% | 772M | |
-0.22% | 761M | |
-26.15% | 619M |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Renalytix Repays $1 Million in Convertible Bonds